Phase 3 IVIG Trial for Stiff Person Syndrome Adults
Summary
A Phase 3 clinical trial evaluating intravenous immunoglobulin (IVIG) as a treatment for Stiff Person Syndrome in adult patients is registered on ClinicalTrials.gov under the identifier NCT07552987. The trial is listed by start date in the registry and presents summary registration details including intervention type, study phase, and condition. No new compliance obligations or regulatory actions are imposed by this registry entry.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 21 changes logged to date.
What changed
This registry entry announces a Phase 3 clinical trial for intravenous immunoglobulin (IVIG) in the treatment of Stiff Person Syndrome in adult patients, posted on ClinicalTrials.gov. The entry provides standard trial registration metadata including the NCT identifier NCT07552987, intervention details, and study phase classification.
Pharmaceutical sponsors, clinical investigators, and healthcare providers involved in rare neurological disease research may find this trial relevant for competitive intelligence and patient referral purposes. The trial registration does not itself impose compliance obligations but reflects ongoing regulatory activity in the rare disease space.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.